title: Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas.
abstract: All low differentiated or anaplastic forms of nasopharyngeal carcinoma (NPC) carry multiple copies of EBV-DNA and express EBNA1. The major membrane protein, LMP1, is only expressed in 65% of the tumours. The physiological function of LMP1 in the viral life cycle is unknown, but it has been shown to transform established rodent fibroblasts and immortalised human keratinocytes in vitro, and to increase the likelihood of a malignant transformation. We studied 74 cases collected from the Shanghai and Guanzhou areas in China. LMP1 expression was assessed in tumour biopsies by immunoblotting. Clinical and follow-up data were evaluated according to the classification of WHO. The laboratory and the clinical data were assembled in a mutually independent double blind fashion. Our findings indicate that the LMP1-positive tumours grew faster and more expansively than LMP1-negative tumours, but nevertheless had a better prognosis. LMP1-negative tumours recurred at a higher frequency, and showed an increased tendency to metastasise.
authors.affiliation: Microbiology and Tumour Biology Centre, Karolinska Institute, Stockholm, Sweden.
authors.forename: L F
authors.initials: LF
authors.lastname: Hu
authors.forename: F
authors.initials: F
authors.lastname: Chen
authors.forename: Q F
authors.initials: QF
authors.lastname: Zhen
authors.forename: Y W
authors.initials: YW
authors.lastname: Zhang
authors.forename: Y
authors.initials: Y
authors.lastname: Luo
authors.forename: X
authors.initials: X
authors.lastname: Zheng
authors.forename: G
authors.initials: G
authors.lastname: Winberg
authors.forename: I
authors.initials: I
authors.lastname: Ernberg
authors.forename: G
authors.initials: G
authors.lastname: Klein
mesh_terms: D002277:Carcinoma / Q000378:metabolism* / Q000473:pathology; D002681:China; D003625:Data Collection / Q000379:methods; D004311:Double-Blind Method; D005500:Follow-Up Studies; D004854:Herpesvirus 4, Human; D006801:Humans; D015151:Immunoblotting; D009303:Nasopharyngeal Neoplasms / Q000378:metabolism* / Q000473:pathology; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000378:metabolism; D009367:Neoplasm Staging; D011379:Prognosis; D014763:Viral Matrix Proteins / Q000378:metabolism*
chemical_list: C037662:EBV-associated membrane antigen, Epstein-Barr virus; D014763:Viral Matrix Proteins